Back to search

Sweden· SE-20190830000043

ABASAGLAR Tempo Pen 100 enheter/ml Injektionsvätska, lösning i förfylld injektionspenna

A medicinal product, registered in Sweden by Eli Lilly Nederland B.V..

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedABASAGLAR Tempo Pen 100 enheter/ml In…ATC—REGISTER NO.SE-20190830000043PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Manufacturer
Eli Lilly Nederland B.V.
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20190830000043

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d9682333-83af-40ef-bb4b-c099524b7ce7
GET /v1/drugs/d9682333-83af-40ef-bb4b-c099524b7ce7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20190830000043",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20190830000043",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/abasaglar-epar-product-information_sv.pdf"
}

See everything about ABASAGLAR.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.